Los Angeles-based Sensydia designed the AI-based, non-invasive CPS to use heart sound analysis. It may enable earlier detection and improved therapy guidance for heart failure and pulmonary hypertension patients.
CPS uses ultra-sensitive biosensors for the rapid, non-invasive measurement of a number of cardiac metrics. These include ejection fraction, cardiac output, pulmonary artery pressure and pulmonary capillary wedge pressure. It all comes together in one handheld device, Sensydia said.
Normally, patients must undergo echocardiography and invasive catheterization to obtain these measurements. CPS offers fast and safe measurements and can be performed almost anywhere with minimal training, according to a news release.
Sensydia conducted the study at the University of Pittsburgh Medica…